Probmet Therapeutics Alternatives & Competitors
12 companies similar to Probmet Therapeutics — An oncology therapeutics company developing new targeted treatments for breast c...
Companies similar to Probmet Therapeutics
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
BeyondSpring
Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to ad...
New York, United States
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
Phoenix Molecular Designs
A clinical stage biopharmaceutical company designing precise cancer therapeutics to addres...
San Diego, United States
Track all Probmet Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
San Diego, United States
Arcus Biosciences
Global, biopharmaceutical company at the forefront of designing precision combinations in...
Hayward, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
United States
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
TransCode Therapeutics, Inc.
Delivering a cancer-free future
Newton, United States
Aimed Bio Inc.
Precision Neurology & Neuro-Oncology for Brain Health
Seoul, Korea South
Incyclix Bio
Regaining Cell Cycle Control
Durham, United States
About Probmet Therapeutics
Probmet Therapeutics, headquartered in Denmark, is making strides in the field of precision oncology with a focus on developing new therapies for metastatic breast cancer in the brain. Founded in 2022, the company operates within the Health Care and Health and Wellness industries. Its core mission revolves around a cri...
Targeted Cancer Treatments, Drug Discovery and Development, Clinical Trial Research, Biomarker Strategy
Breast Cancer Patients with Brain Metastasis, Oncologists and Clinical Researchers, Pharmaceutical and Biotech Companies
Oncology Therapeutics, Targeted Treatments, Breast Cancer, Brain Metastasis, Precision Medicine, Metastatic Cancer, Therapeutic Development, Innovation In Cancer Treatment, Breakthrough Therapies, Neuroscience Oncology, Cancer Research, Pharmaceuticals
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Probmet Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Probmet Therapeutics on 14 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
